Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,805 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in Taiwan.
Yu ML, Yeh ML, Tsai PC, Huang CI, Huang JF, Huang CF, Hsieh MH, Liang PC, Lin YH, Hsieh MY, Lin WY, Hou NJ, Lin ZY, Chen SC, Dai CY, Chuang WL, Chang WY. Yu ML, et al. Among authors: lin wy, lin yh, lin zy. Medicine (Baltimore). 2015 Apr;94(13):e690. doi: 10.1097/MD.0000000000000690. Medicine (Baltimore). 2015. PMID: 25837762 Free PMC article.
Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized Study.
Yeh ML, Hsieh MY, Huang CI, Huang CF, Hsieh MH, Liang PC, Lin YH, Hou NJ, Lin ZY, Chen SC, Huang JF, Dai CY, Chuang WL, Yu ML. Yeh ML, et al. Among authors: lin yh, lin zy. Medicine (Baltimore). 2015 Oct;94(42):e1837. doi: 10.1097/MD.0000000000001837. Medicine (Baltimore). 2015. PMID: 26496327 Free PMC article. Clinical Trial.
Dynamics of PBMC gene expression in hepatitis C virus genotype 1-infected patients during combined peginterferon/ribavirin therapy.
Lu MY, Huang CI, Hsieh MY, Hsieh TJ, Hsi E, Tsai PC, Tsai YS, Lin CC, Hsieh MH, Liang PC, Lin YH, Hou NJ, Yeh ML, Huang CF, Lin ZY, Chen SC, Huang JF, Chuang WL, Dai CY, Yu ML. Lu MY, et al. Among authors: lin cc, lin yh, lin zy. Oncotarget. 2016 Sep 20;7(38):61325-61335. doi: 10.18632/oncotarget.11348. Oncotarget. 2016. PMID: 27542257 Free PMC article.
A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in Taiwan.
Tsai PC, Liu TW, Hsieh MH, Yeh ML, Liang PC, Lin YH, Huang CI, Huang CF, Hsieh MY, Hou NJ, Lin ZY, Chen SC, Huang JF, Dai CY, Chuang WL, Yu ML. Tsai PC, et al. Among authors: lin yh, lin zy. Kaohsiung J Med Sci. 2017 Jan;33(1):44-49. doi: 10.1016/j.kjms.2016.10.008. Epub 2016 Nov 18. Kaohsiung J Med Sci. 2017. PMID: 28088273 Free article.
Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohort.
Liu TW, Tsai PC, Huang CI, Tsai YS, Wang SC, Ko YM, Lin CC, Chen KY, Liang PC, Lin YH, Hsieh MY, Hou NJ, Huang CF, Yeh ML, Lin ZY, Chen SC, Dai CY, Chuang WL, Huang JF, Yu ML. Liu TW, et al. Among authors: lin cc, lin yh, lin zy. J Formos Med Assoc. 2018 Jan;117(1):54-62. doi: 10.1016/j.jfma.2017.02.013. Epub 2017 Apr 4. J Formos Med Assoc. 2018. PMID: 28389143 Free article.
3,805 results